• Wada defends decision not to make Froome undergo CPKT study
The World Anti-Doping Agency is considering whether to slash the daily permissible limit of salbutamol, the asthma medication at the centre of the Chris Froome case, the Guardian can reveal. Wada’s director general, Olivier Niggli, also raised the possibility of Wada lowering the dosage for which a TUE for salbutamol would be required.
The UCI’s decision last week to clear Froome, who had tested for double the permitted amount of salbutamol at the Vuelta a España in September, has led to stinging criticisms of Wada’s science, which continued even after it released a more detailed statement explaining its decision not to appeal the UCI ruling on Wednesday.
Written by Sean Ingle
This news first appeared on https://www.theguardian.com/sport/2018/jul/13/chris-froome-wada-permitted-level-salbutamol-cut under the title “Wada may cut permitted limit of medication at centre of Froome case”. Bolchha Nepal is not responsible or affiliated towards the opinion expressed in this news article.
